Home » Topics » Conferences

Conferences
RSS

UDCA suppresses allograft rejection after heart transplant

Sep. 3, 1997

Preclinical results with L-FMAU, an anti-HBV agent

Sep. 3, 1997

Spotlight on endothelin receptor antagonists in cardiovascular medicine

Sep. 3, 1997

Spotlight on Na+/H+-exchange inhibitors

Sep. 3, 1997

HRT and cardiovascular disease in women

Sep. 2, 1997

Gene therapy for cardiovascular diseases

Sep. 2, 1997

Link between high blood pressure and cancer debated

Sep. 2, 1997

Reteplase is superior to alteplase in pulmonary embolism

Sep. 2, 1997

Final results of BENESTENT-II trial presented

Sep. 2, 1997

New therapeutic action of aspirin reported by British researchers

Sep. 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...